Vol 2 (June 2017): Journal of Xiangya Medicine

Editorial
The MCL-1 inhibitor S63845: an exciting new addition to the armoury of anti-cancer agents
Jason A. Powell, Alexander C. Lewis, Stuart M. Pitson
Journal of Xiangya Medicine  
2017;
2:
53  
(20 June 2017) 
PDF Full Text (5009) COI Form Open Access Get Permission
Original Article
Totally laparoscopic intragastric surgery for gastric submucosal tumors located near the esophagogastric junction
Zhiming Ma, Tianzhou Liu, Xuedong Fang, Jingjing Liu, Pengda Sun, Jiaming Zhu
Journal of Xiangya Medicine  
2017;
2:
52  
(12 June 2017) 
PDF Full Text (2151) COI Form Open Access Get Permission
Editorial
Early persistent retinal fluid during treatment of neovascular AMD with ranibizumab and aflibercept
João Pedro Marques, José Cunha-Vaz
Journal of Xiangya Medicine  
2017;
2:
51  
(07 June 2017) 
PDF Full Text (1859) COI Form Open Access Get Permission
Review Article
Individualized multidisciplinary treatment options for hepatocellular carcinoma in the department of liver surgery: experiences in Xiangya Hospital of Central South University
Yiming Tao, Zhiming Wang
Journal of Xiangya Medicine  
2017;
2:
50  
(07 June 2017) 
PDF Full Text (2621) COI Form Open Access Get Permission
Original Article
Phyllodes tumor of the breast—not all are self-detected
Eva Ruvalcaba-Limón, Verónica Bautista-Piña, Felipe Villegas-Carlos, Ruby Espejo-Fonseca, Nora Moguel-Molina, Juan Alberto Tenorio-Torres, Sergio Rodríguez-Cuevas
Journal of Xiangya Medicine  
2017;
2:
49  
(04 June 2017) 
PDF Full Text (3326) COI Form Open Access Get Permission
Mini-Review
Lung volume reduction surgery in selected patients with severe emphysema: significant benefit with low peri-operative risk
Claudio Caviezel
Journal of Xiangya Medicine  
2017;
2:
48  
(03 June 2017) 
PDF Full Text (3251) COI Form Open Access Get Permission